Intracranial Drug Eluting Stents Market

Intracranial Drug Eluting Stents Market contains market size and forecasts of Intracranial Drug Eluting Stents in global, including the following market information:

Global Intracranial Drug Eluting Stents Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Intracranial Drug Eluting Stents Market Sales, 2017-2022, 2023-2028, (Units)

Global top five Intracranial Drug Eluting Stents companies in 2021 (%)

The global Intracranial Drug Eluting Stents market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cobalt-chromium Alloy Stents Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Intracranial Drug Eluting Stents include Abbott, Medtronic Vascular, Advantec Vascular, B.Braun Melsengen, Boston Scientific, Terumo Medical, Biosensors, Biotronik and Blue Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Intracranial Drug Eluting Stents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Intracranial Drug Eluting Stents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Intracranial Drug Eluting Stents Market Segment Percentages, by Type, 2021 (%)

• Cobalt-chromium Alloy Stents
• Magnesium Alloy Stents
• Stainless Steel Stents
• Others

Global Intracranial Drug Eluting Stents Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Intracranial Drug Eluting Stents Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Specialty Clinic
• Others

Global Intracranial Drug Eluting Stents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Intracranial Drug Eluting Stents Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Intracranial Drug Eluting Stents revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Intracranial Drug Eluting Stents revenues share in global market, 2021 (%)
• Key companies Intracranial Drug Eluting Stents sales in global market, 2017-2022 (Estimated), (Units)
• Key companies Intracranial Drug Eluting Stents sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Medtronic Vascular
• Advantec Vascular
• B.Braun Melsengen
• Boston Scientific
• Terumo Medical
• Biosensors
• Biotronik
• Blue Medical
• DISA Vascular
• Essen
• MicroPort Medical
• MIV Therapeutics
• Orbusneich
• Promed Medical
• Relisys Medical
• Reva Medical
• Sahajanand
• Sino Medical
• Sorin
• TEDA